SAN DIEGO, Feb. 7, 2023 /PRNewswire/ — Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that its chief executive officer, Brian Lian, Ph.D.,…
Viking Therapeutics to Present at SVB Securities Global Biopharma Conference
